GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Float Percentage Of Total Shares Outstanding

Rhinomed (ASX:RNO) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 24, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rhinomed's float shares is 0.00 Mil. Rhinomed's total shares outstanding is 286.77 Mil. Rhinomed's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rhinomed's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rhinomed's Institutional Ownership is 0.52%.

Rhinomed Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Rhinomed's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/286.77
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhinomed (ASX:RNO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ASX:VTI ASX:IRX ASX:CBL ASX:HMD ASX:UCM ASX:OSL ASX:AT1 ASX:AMT ASX:LBT ASX:CSX ABT SYK MDT BSX EW SZSE:300760 DXCM ZBH ALGN STE
Traded in Other Exchanges
RHNMF:USA
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Website
https://www.rhinomed.global
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines